1.
Zalewski JZ, Cyrzan A, StyczyƄska M, Iwanowska M, Flis B, Zysk A, et al. How does the use of GLP-1 receptor agonists affect bone mineral density and fracture risk in obese individuals?. J Educ Health Sport [Internet]. 2026 Feb. 4 [cited 2026 Feb. 5];87:68397. Available from: https://apcz.umk.pl/JEHS/article/view/68397